Injective will be listing The Graph (GRT) on the Solstice V2 Testnet! This means along with the upcoming public launch of the testnet, users will be able to trade GRT perpetual markets with up to 20x leverage.

The Graph is an indexing protocol for querying data for networks like Ethereum and IPFS, powering many applications in both DeFi and the broader Web3 ecosystem. Anyone can build and publish open APIs, called subgraphs, that applications can query using GraphQL to retrieve blockchain data. The Graph currently supports indexing data from Ethereum, IPFS and POA, with more networks coming soon.

The Graph team includes individuals from the Ethereum Foundation, OpenZeppelin, and Decentraland. Developers in the Injective community have used The Graph’s products for quite some time, so this is a natural next step in introducing GRT asset derivatives. This asset addition also helps to further accelerate Injective’s rapid market growth as Injective has already introduced various popular assets, synthetic commodity trading, and a plethora of DeFi assets.

The goal of the Injective community is to provide limitless markets for traders globally. In addition to recently introducing the world’s first yield farming derivatives, listing GRT further demonstrates the goal to bring diverse markets such as those related to yield farming well as fast-growing native crypto assets to the DEX. New asset additions will be pursued in order to deliver a fully decentralized trading experience that offers limitless opportunities for all.

About Injective

Injective is the first cross-chain protocol built for decentralized finance applications. On the Injective exchange, anyone can access, create, and trade unlimited DeFi markets such as futures and perpetuals. Developers can also build cross-chain Ethereum-compatible projects that are lightning fast and achieve instant transaction finality. Injective is backed by a prominent group of stakeholders including Binance, Pantera Capital and Mark Cuban.

Website | Telegram | Discord | Blog | Twitter | Learn | Youtube | Facebook | LinkedIn | Reddit | Instagram | Weibo | Orbit Newsletter